321 related articles for article (PubMed ID: 31738367)
1. Survival and Prognostic Factors in C9orf72 Repeat Expansion Carriers: A Systematic Review and Meta-analysis.
Glasmacher SA; Wong C; Pearson IE; Pal S
JAMA Neurol; 2020 Mar; 77(3):367-376. PubMed ID: 31738367
[TBL] [Abstract][Full Text] [Related]
2. Clinical and neuropathologic heterogeneity of c9FTD/ALS associated with hexanucleotide repeat expansion in C9ORF72.
Murray ME; DeJesus-Hernandez M; Rutherford NJ; Baker M; Duara R; Graff-Radford NR; Wszolek ZK; Ferman TJ; Josephs KA; Boylan KB; Rademakers R; Dickson DW
Acta Neuropathol; 2011 Dec; 122(6):673-90. PubMed ID: 22083254
[TBL] [Abstract][Full Text] [Related]
3. Molecular Mechanisms of Neurodegeneration Related to
Babić Leko M; Župunski V; Kirincich J; Smilović D; Hortobágyi T; Hof PR; Šimić G
Behav Neurol; 2019; 2019():2909168. PubMed ID: 30774737
[TBL] [Abstract][Full Text] [Related]
4. C9ORF72 repeat expansion in clinical and neuropathologic frontotemporal dementia cohorts.
Dobson-Stone C; Hallupp M; Bartley L; Shepherd CE; Halliday GM; Schofield PR; Hodges JR; Kwok JB
Neurology; 2012 Sep; 79(10):995-1001. PubMed ID: 22875086
[TBL] [Abstract][Full Text] [Related]
5. C9orf72 and RAB7L1 regulate vesicle trafficking in amyotrophic lateral sclerosis and frontotemporal dementia.
Aoki Y; Manzano R; Lee Y; Dafinca R; Aoki M; Douglas AGL; Varela MA; Sathyaprakash C; Scaber J; Barbagallo P; Vader P; Mäger I; Ezzat K; Turner MR; Ito N; Gasco S; Ohbayashi N; El Andaloussi S; Takeda S; Fukuda M; Talbot K; Wood MJA
Brain; 2017 Apr; 140(4):887-897. PubMed ID: 28334866
[TBL] [Abstract][Full Text] [Related]
6. Screening for the C9ORF72 repeat expansion in a greek frontotemporal dementia cohort.
Kartanou C; Karadima G; Koutsis G; Breza M; Papageorgiou SG; Paraskevas GP; Kapaki E; Panas M
Amyotroph Lateral Scler Frontotemporal Degener; 2018 Feb; 19(1-2):152-154. PubMed ID: 29166782
[TBL] [Abstract][Full Text] [Related]
7. Longitudinal imaging in
Floeter MK; Bageac D; Danielian LE; Braun LE; Traynor BJ; Kwan JY
Neuroimage Clin; 2016; 12():1035-1043. PubMed ID: 27995069
[TBL] [Abstract][Full Text] [Related]
8. Multiple variants in families with amyotrophic lateral sclerosis and frontotemporal dementia related to C9orf72 repeat expansion: further observations on their oligogenic nature.
Giannoccaro MP; Bartoletti-Stella A; Piras S; Pession A; De Massis P; Oppi F; Stanzani-Maserati M; Pasini E; Baiardi S; Avoni P; Parchi P; Liguori R; Capellari S
J Neurol; 2017 Jul; 264(7):1426-1433. PubMed ID: 28620717
[TBL] [Abstract][Full Text] [Related]
9. Characterization of DNA hypermethylation in the cerebellum of c9FTD/ALS patients.
Belzil VV; Bauer PO; Gendron TF; Murray ME; Dickson D; Petrucelli L
Brain Res; 2014 Oct; 1584():15-21. PubMed ID: 24530272
[TBL] [Abstract][Full Text] [Related]
10. Frontotemporal dementia due to C9ORF72 mutations: clinical and imaging features.
Sha SJ; Takada LT; Rankin KP; Yokoyama JS; Rutherford NJ; Fong JC; Khan B; Karydas A; Baker MC; DeJesus-Hernandez M; Pribadi M; Coppola G; Geschwind DH; Rademakers R; Lee SE; Seeley W; Miller BL; Boxer AL
Neurology; 2012 Sep; 79(10):1002-11. PubMed ID: 22875087
[TBL] [Abstract][Full Text] [Related]
11. Frontotemporal dementia with amyotrophic lateral sclerosis: a clinical comparison of patients with and without repeat expansions in C9orf72.
Snowden JS; Harris J; Richardson A; Rollinson S; Thompson JC; Neary D; Mann DM; Pickering-Brown S
Amyotroph Lateral Scler Frontotemporal Degener; 2013 Apr; 14(3):172-6. PubMed ID: 23421625
[TBL] [Abstract][Full Text] [Related]
12. Chimeric Peptide Species Contribute to Divergent Dipeptide Repeat Pathology in c9ALS/FTD and SCA36.
McEachin ZT; Gendron TF; Raj N; García-Murias M; Banerjee A; Purcell RH; Ward PJ; Todd TW; Merritt-Garza ME; Jansen-West K; Hales CM; García-Sobrino T; Quintáns B; Holler CJ; Taylor G; San Millán B; Teijeira S; Yamashita T; Ohkubo R; Boulis NM; Xu C; Wen Z; Streichenberger N; ; Fogel BL; Kukar T; Abe K; Dickson DW; Arias M; Glass JD; Jiang J; Tansey MG; Sobrido MJ; Petrucelli L; Rossoll W; Bassell GJ
Neuron; 2020 Jul; 107(2):292-305.e6. PubMed ID: 32375063
[TBL] [Abstract][Full Text] [Related]
13. Different CSF protein profiles in amyotrophic lateral sclerosis and frontotemporal dementia with
Barschke P; Oeckl P; Steinacker P; Al Shweiki MR; Weishaupt JH; Landwehrmeyer GB; Anderl-Straub S; Weydt P; Diehl-Schmid J; Danek A; Kornhuber J; Schroeter ML; Prudlo J; Jahn H; Fassbender K; Lauer M; van der Ende EL; van Swieten JC; Volk AE; Ludolph AC; Otto M;
J Neurol Neurosurg Psychiatry; 2020 May; 91(5):503-511. PubMed ID: 32132225
[TBL] [Abstract][Full Text] [Related]
14. BET bromodomain inhibitors PFI-1 and JQ1 are identified in an epigenetic compound screen to enhance C9ORF72 gene expression and shown to ameliorate C9ORF72-associated pathological and behavioral abnormalities in a C9ALS/FTD model.
Quezada E; Cappelli C; Diaz I; Jury N; Wightman N; Brown RH; Montecino M; van Zundert B
Clin Epigenetics; 2021 Mar; 13(1):56. PubMed ID: 33726839
[TBL] [Abstract][Full Text] [Related]
15. C9orf72 hexanucleotide repeat expansions as the causative mutation for chromosome 9p21-linked amyotrophic lateral sclerosis and frontotemporal dementia.
Daoud H; Suhail H; Sabbagh M; Belzil V; Szuto A; Dionne-Laporte A; Khoris J; Camu W; Salachas F; Meininger V; Mathieu J; Strong M; Dion PA; Rouleau GA
Arch Neurol; 2012 Sep; 69(9):1159-63. PubMed ID: 22964911
[TBL] [Abstract][Full Text] [Related]
16. Clinical and neuropathological features of ALS/FTD with TIA1 mutations.
Hirsch-Reinshagen V; Pottier C; Nicholson AM; Baker M; Hsiung GR; Krieger C; Sengdy P; Boylan KB; Dickson DW; Mesulam M; Weintraub S; Bigio E; Zinman L; Keith J; Rogaeva E; Zivkovic SA; Lacomis D; Taylor JP; Rademakers R; Mackenzie IRA
Acta Neuropathol Commun; 2017 Dec; 5(1):96. PubMed ID: 29216908
[TBL] [Abstract][Full Text] [Related]
17. [Impact of C9orf72 on Japanese Patients with Amytrophic Lateral Sclerosis (ALS)/Frontotemporal Dementia (FTD)].
Tomiyama H
Brain Nerve; 2019 Nov; 71(11):1190-1208. PubMed ID: 31722305
[TBL] [Abstract][Full Text] [Related]
18. Screening a UK amyotrophic lateral sclerosis cohort provides evidence of multiple origins of the C9orf72 expansion.
Fratta P; Polke JM; Newcombe J; Mizielinska S; Lashley T; Poulter M; Beck J; Preza E; Devoy A; Sidle K; Howard R; Malaspina A; Orrell RW; Clarke J; Lu CH; Mok K; Collins T; Shoaii M; Nanji T; Wray S; Adamson G; Pittman A; Renton AE; Traynor BJ; Sweeney MG; Revesz T; Houlden H; Mead S; Isaacs AM; Fisher EM
Neurobiol Aging; 2015 Jan; 36(1):546.e1-7. PubMed ID: 25179228
[TBL] [Abstract][Full Text] [Related]
19. Characterization of a family with c9FTD/ALS associated with the GGGGCC repeat expansion in C9ORF72.
Savica R; Adeli A; Vemuri P; Knopman DS; Dejesus-Hernandez M; Rademakers R; Fields JA; Whitwell J; Jack CR; Lowe V; Petersen RC; Boeve BF
Arch Neurol; 2012 Sep; 69(9):1164-9. PubMed ID: 22637471
[TBL] [Abstract][Full Text] [Related]
20. The First Historically Reported Italian Family with FTD/ALS Teaches a Lesson on C9orf72 RE: Clinical Heterogeneity and Oligogenic Inheritance.
Giannoccaro MP; Bartoletti-Stella A; Piras S; Casalena A; Oppi F; Ambrosetto G; Montagna P; Liguori R; Parchi P; Capellari S
J Alzheimers Dis; 2018; 62(2):687-697. PubMed ID: 29480190
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
